The use of angiotensin-converting enzyme (ACE) inhibitors may impact a patient’s compensatory physiologic response to anaphylaxis, resulting in more severe reactions, although the evidence is conflicting (6, 23). This evidence concerns the gene ACE and anaphylaxis.